Published in AIDS Weekly, July 31st, 2000
"Many hemophilic individuals infected with HIV died before receiving antiretroviral therapy (ART)," wrote C.A. Sabin and colleagues, Royal Free & University College Medical School, England. "Most who remain alive are chronically infected with hepatitis C virus (HCV), which has implications for their prognosis and choice of ART. The clinical status of a cohort of HIV positive hemophilic men is reported together with their response to HAART."
They collected their data from a longitudinal cohort study...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.